199 related articles for article (PubMed ID: 17584049)
1. Human embryonic stem cell-derived cardiomyocytes for heart therapies.
Siu CW; Moore JC; Li RA
Cardiovasc Hematol Disord Drug Targets; 2007 Jun; 7(2):145-52. PubMed ID: 17584049
[TBL] [Abstract][Full Text] [Related]
2. Embryonic stem cell transplantation: promise and progress in the treatment of heart disease.
Zhang F; Pasumarthi KB
BioDrugs; 2008; 22(6):361-74. PubMed ID: 18998754
[TBL] [Abstract][Full Text] [Related]
3. Human embryonic stem cells vs human induced pluripotent stem cells for cardiac repair.
Barad L; Schick R; Zeevi-Levin N; Itskovitz-Eldor J; Binah O
Can J Cardiol; 2014 Nov; 30(11):1279-87. PubMed ID: 25442431
[TBL] [Abstract][Full Text] [Related]
4. Functional properties of human embryonic stem cell-derived cardiomyocytes.
Zeevi-Levin N; Itskovitz-Eldor J; Binah O
Crit Rev Eukaryot Gene Expr; 2010; 20(1):51-9. PubMed ID: 20528737
[TBL] [Abstract][Full Text] [Related]
5. Human pluripotent stem cell-based approaches for myocardial repair: from the electrophysiological perspective.
Poon E; Kong CW; Li RA
Mol Pharm; 2011 Oct; 8(5):1495-504. PubMed ID: 21879736
[TBL] [Abstract][Full Text] [Related]
6. Functional and developmental properties of human embryonic stem cells-derived cardiomyocytes.
Binah O; Dolnikov K; Sadan O; Shilkrut M; Zeevi-Levin N; Amit M; Danon A; Itskovitz-Eldor J
J Electrocardiol; 2007; 40(6 Suppl):S192-6. PubMed ID: 17993321
[TBL] [Abstract][Full Text] [Related]
7. Stem cells in cardiac repair.
Henning RJ
Future Cardiol; 2011 Jan; 7(1):99-117. PubMed ID: 21174514
[TBL] [Abstract][Full Text] [Related]
8. Translational potential of human embryonic and induced pluripotent stem cells for myocardial repair: insights from experimental models.
Kong CW; Akar FG; Li RA
Thromb Haemost; 2010 Jul; 104(1):30-8. PubMed ID: 20539906
[TBL] [Abstract][Full Text] [Related]
9. Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers.
Xue T; Cho HC; Akar FG; Tsang SY; Jones SP; Marbán E; Tomaselli GF; Li RA
Circulation; 2005 Jan; 111(1):11-20. PubMed ID: 15611367
[TBL] [Abstract][Full Text] [Related]
10. Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat hearts.
Dai W; Field LJ; Rubart M; Reuter S; Hale SL; Zweigerdt R; Graichen RE; Kay GL; Jyrala AJ; Colman A; Davidson BP; Pera M; Kloner RA
J Mol Cell Cardiol; 2007 Oct; 43(4):504-16. PubMed ID: 17707399
[TBL] [Abstract][Full Text] [Related]
11. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts.
Caspi O; Huber I; Kehat I; Habib M; Arbel G; Gepstein A; Yankelson L; Aronson D; Beyar R; Gepstein L
J Am Coll Cardiol; 2007 Nov; 50(19):1884-93. PubMed ID: 17980256
[TBL] [Abstract][Full Text] [Related]
12. Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts.
Chong JJ; Yang X; Don CW; Minami E; Liu YW; Weyers JJ; Mahoney WM; Van Biber B; Cook SM; Palpant NJ; Gantz JA; Fugate JA; Muskheli V; Gough GM; Vogel KW; Astley CA; Hotchkiss CE; Baldessari A; Pabon L; Reinecke H; Gill EA; Nelson V; Kiem HP; Laflamme MA; Murry CE
Nature; 2014 Jun; 510(7504):273-7. PubMed ID: 24776797
[TBL] [Abstract][Full Text] [Related]
13. Functional sarcoplasmic reticulum for calcium handling of human embryonic stem cell-derived cardiomyocytes: insights for driven maturation.
Liu J; Fu JD; Siu CW; Li RA
Stem Cells; 2007 Dec; 25(12):3038-44. PubMed ID: 17872499
[TBL] [Abstract][Full Text] [Related]
14. The use of aggregates of purified cardiomyocytes derived from human ESCs for functional engraftment after myocardial infarction.
Moon SH; Kang SW; Park SJ; Bae D; Kim SJ; Lee HA; Kim KS; Hong KS; Kim JS; Do JT; Byun KH; Chung HM
Biomaterials; 2013 May; 34(16):4013-4026. PubMed ID: 23465823
[TBL] [Abstract][Full Text] [Related]
15. Innovation in basic science: stem cells and their role in the treatment of paediatric cardiac failure--opportunities and challenges.
Kaushal S; Jacobs JP; Gossett JG; Steele A; Steele P; Davis CR; Pahl E; Vijayan K; Asante-Korang A; Boucek RJ; Backer CL; Wold LE
Cardiol Young; 2009 Nov; 19 Suppl 2():74-84. PubMed ID: 19857353
[TBL] [Abstract][Full Text] [Related]
16. New directions in strategies using cell therapy for heart disease.
Itescu S; Schuster MD; Kocher AA
J Mol Med (Berl); 2003 May; 81(5):288-96. PubMed ID: 12698252
[TBL] [Abstract][Full Text] [Related]
17. Human embryonic stem cells and cardiac repair.
Zhu WZ; Hauch KD; Xu C; Laflamme MA
Transplant Rev (Orlando); 2009 Jan; 23(1):53-68. PubMed ID: 18657407
[TBL] [Abstract][Full Text] [Related]
18. Maturation of human embryonic stem cell-derived cardiomyocytes (hESC-CMs) in 3D collagen matrix: Effects of niche cell supplementation and mechanical stimulation.
Zhang W; Kong CW; Tong MH; Chooi WH; Huang N; Li RA; Chan BP
Acta Biomater; 2017 Feb; 49():204-217. PubMed ID: 27890729
[TBL] [Abstract][Full Text] [Related]
19. Human embryonic stem cell-derived cardiomyocytes: demonstration of a portion of cardiac cells with fairly mature electrical phenotype.
Pekkanen-Mattila M; Chapman H; Kerkelä E; Suuronen R; Skottman H; Koivisto AP; Aalto-Setälä K
Exp Biol Med (Maywood); 2010 Apr; 235(4):522-30. PubMed ID: 20407085
[TBL] [Abstract][Full Text] [Related]
20. Labeling human embryonic stem cell-derived cardiomyocytes with indocyanine green for noninvasive tracking with optical imaging: an FDA-compatible alternative to firefly luciferase.
Boddington SE; Henning TD; Jha P; Schlieve CR; Mandrussow L; DeNardo D; Bernstein HS; Ritner C; Golovko D; Lu Y; Zhao S; Daldrup-Link HE
Cell Transplant; 2010; 19(1):55-65. PubMed ID: 20370988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
